In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Uriach, Organon develop inflammatory disorder therapies

Executive Summary

Akzo Nobel NV's human health care business Organon USA (reproductive medicine, psychiatry, and anesthesia) and Spanish pharmaceutical company J. Uriach & Cia. SA's (focuses on inflammation) are collaborating to discover, develop, and commercialize therapeutics to treat inflammatory diseases, particularly rheumatoid arthritis.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies